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a  b  s  t  r  a  c  t
Campylobacter  is the  leading  cause  of  food-borne  diarrhoea  in humans  in the  developed  world  and  con-
sumption  of  contaminated  poultry  meat  is  the  main  source  of  infection.  Vaccination  of  broilers  could
reduce  carcass  contamination  and  zoonotic  infections.  Towards  this  aim,  we  evaluated  recombinant  anti-
Campylobacter  subunit  vaccines  based  on  the  ﬂagellum-capping  protein  FliD  and  the ﬂagellum-secreted
protein  FspA  as  they  are  immunogenic  in  chickens  and  the  ﬂagellum  is  vital  for  colonisation.  In  three  stud-
ies,  a recombinant  FliD  vaccine  induced  a transient  but  reproducible  and  statistically  signiﬁcant  decreaseeywords:
ampylobacter jejuni
hickens
ubunit
accine
lagellar cap protein
of c.  2 log10 CFU/g  in  caecal  colonisation  levels  at 49  days  post-primary  vaccination  on  the  day  of hatch.
Levels  of  serum  IgY  speciﬁc  to  FliD  positively  correlated  with  caecal  bacterial  counts  in individual  birds,
indicating  that  such  antibodies  may  not  play  a role  in protection.  The data  add to the  limited  repertoire
of  candidate  antigens  for  the  control  of a  key foodborne  zoonosis.
© 2016  The  Authors.  Published  by  Elsevier  Ltd.  This  is  an  open  access  article  under the  CC  BY license
lagellum secreted protein
. Introduction
Campylobacter is the leading cause of food-borne diarrhoeal dis-
ase in the developed world and the European Food Standards
gency has predicted that nine million cases of human campy-
obacteriosis occur every year across EU27 countries, resulting in
.35 million disability-adjusted life years per annum and a cost of
 2.4 billion [1]. Source attribution studies show that up to 80% of
uman cases may  be linked to consumption or handling of con-
aminated poultry meat [1]. A reduction in carcass contamination
f 2 log10 CFU/g of caecal contents has been predicted to result in a
ecrease of up to 30-fold in cases of human infection due to poul-
ry [2], however few effective treatments or vaccines have been
escribed. Given that the latest UK-wide surveys reported contam-
nation of 73% of raw chicken on sale during the 2014–2015 year
3] and an estimated 685,000 human infections in 2013 [4], there
s a compelling case for vaccination of poultry at the farm level.
Previous vaccination studies have evaluated ﬂagellin subunits
s the ﬂagellum is vital for colonisation of the avian intestines
5–7]. The ﬂagellin-based vaccines showed variable levels of pro-
ection and failed to induce heterologous protection, possibly due
o glycosylation of ﬂagella which can vary with the strain [8,9] and
hase variation [10]. In order to address these limitations we  tested
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ttp://dx.doi.org/10.1016/j.vaccine.2016.02.052
264-410X/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article u(http://creativecommons.org/licenses/by/4.0/).
two other ﬂagellum-related proteins as recombinant puriﬁed sub-
unit vaccines: FliD, the ﬂagellar cap protein [11], a 70 kD protein
with a minimum protein sequence conservation of 91% identity
across the Campylobacter jejuni entries available in National Cen-
tre for Biotechnology Information’s database and FspA, a ﬂagellum
secreted protein [12] with a molecular weight of 16.5 kD and a mini-
mum protein conservation of 97%. FliD is known to be immunogenic
following natural infection of Campylobacter in broilers [13] and is
one of the proteins recognised by maternal antibodies transferred
in the egg [14]. Maternal antibodies are thought to delay colonisa-
tion of chicks by Campylobacter in the ﬁrst few weeks of life [15].
FspA has been demonstrated to be protective against clinical signs
and colonisation in a mouse vaccination and challenge model of C.
jejuni infection [16].
This report describes the development and testing of FliD and
FspA subunit vaccines and demonstrates that FliD, but not FspA,
induces transient but statistically signiﬁcant and reproducible pro-
tection in vaccinated chickens. This study adds a novel antigen to
the limited repertoire of protective candidates for control of Campy-
lobacter in the avian reservoir.
2. MethodsBacterial culture was  carried out as described previously [18].
Strains used are detailed in Table 1. Expression vectors for pro-
duction of C. jejuni strain M1 CjaA, FliD and FspA as C-terminal
fusions to glutathione-S-transferase (GST) were prepared by
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Table  1
Bacterial strains, plasmids and primers used in this study.
Strain or
plasmid
Description Source or
reference
Use Primers used for constructiona
E. coli XL1 Blue F− (f80dlacZDM15)
D(lacZYA-argF)U169
recAl endAl
hsdRl7(rk − mk + )
supE44 l− thi-l gyrA relA
Invitrogen, UK Production and
propagation of plasmid
constructs.
N/A
E. coli Rosetta
pLysE BL21
(DE3)
F− ompT hsdSB(rB− ,
mB−) dcm gal (DE3)
Novagen, UK Expression of
GST-tagged proteins
N/A
C.  jejuni M1  Wild-type human
isolate
[17] Source of gDNA for
cloning of antigens and
model strain for
challenge of chickens
N/A
pGEX-4T1 Vector for expression
of recombinant
proteins fused to the C
terminus of GST, under
a  lac promoter
GE Lifesciences,
UK
Expression of
GST-tagged
Campylobacter antigens
and of GST alone.
N/A
pGEX-4T1-cjaA C. jejuni M1  cjaA fused
3′ to GST in pGEX-4T1
This study Expression of
GST-tagged CjaA
Fwd:
5′CGCGCGGGATCCATGAAAAAAATACTTCTAAG3’′
Rev:
5′GCGCGCGGCCGCTTAAATTTTTCCACCTTCAA3′
pGEX-4T1-ﬂiD C. jejuni M1  ﬂiD fused
3′ to GST in pGEX-4T1
This study Expression of
GST-tagged FliD
Fwd:
5′CGCGCGGGATCCATGGCATTTGGTAGTCTATC3′
Rev:
5′GCGCGCGGCCGCTTAATTATTAGAATTGTTTG3′
pGEX-4T1-fspA C. jejuni M1  fspA fused
3′ to GST in pGEX-4T1
This study Expression of
GST-tagged FspA
Fwd:
5′CGCGCGGGATCCATGCAAATTAACAATTCCTT3′
Rev:
5′CGCGCGCGGCCGCTCAAGCTTGTTGGCTTTGGA3′
estriction enzymes used for cloning.
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Fig. 1. GST-tagged recombinant Campylobacter antigens used in vaccination exper-
iments in chickens. (A) Silver staining of typical preparations of GST-tagged
Campylobacter antigens used in vaccination experiments in chickens. (B) Purity of
the protein preparations shown in panel A assessed via a Western blot with ana Underlined sequences represent sequences recognised by the BamHI and NotI r
igation of restriction endonuclease-digested PCR amplicons with
lasmid pGEX-4T1 essentially as we described [19]. Plasmid con-
tructs and the primers and enzymes used for their production
re given in Table 1. Constructs were veriﬁed by dideoxy chain-
ermination sequencing (Source Bioscience, UK) and transformed in
scherichia coli Rosetta (Novagen, UK) for expression of the recom-
inant proteins. Strains were grown at either 28 ◦C for expression
rom pGEX-4T1-cjaA and pGEX-4T1-ﬂiD or 37 ◦C for expres-
ion from pGEX-4T1 and pGEX-4T1-fspA. Cultures were induced
ith either 0.1 mM isopropyl -d-1-thiogalactopyranoside (IPTG;
GEX-4T1-cjaA and pGEX-4T1-ﬂiD) or 1 mM IPTG (pGEX-4T1 and
GEX-4T1-fspA). Puriﬁcation was undertaken as described [18] in
atch format using glutathione sepharose beads (GE Lifesciences,
K) following manufacturer’s protocol with elution in 40 mM
lutathione.
Protein preparations were validated by Western blotting using
 rabbit anti-GST antibody (Santa Cruz Biotechnology, USA) at
:10,000 dilution and bound antibody was detected with an
RP-conjugated anti-rabbit IgG (Sigma–Aldrich, UK) at 1:10,000
ilution.
Once validated, the puriﬁed Campylobacter antigens were tested
or their protective efﬁcacy in chickens. All procedures were
onducted under Home Ofﬁce licence 60/4420, according to the
equirements of the Animal (Scientiﬁc Procedures) Act 1986, and
ith the approval of the local ethical review committee. The line
f birds, adjuvant and the schedule of vaccination and challenge
ere as described [18] to permit comparison with earlier work. A
otal of 240 White Leghorn chickens were used and obtained on the
ay of hatch from a Home Ofﬁce licensed breeding establishment.
rieﬂy, three separate studies were conducted, each with the same
esign, including vaccination with GST or GST-CjaA as negative
nd positive controls, respectively. Birds were given the primary
accination on the day of hatch, a booster 14 days later and chal-
enged with 107 CFU of C. jejuni M1  at 28 days post-hatch (dph). For
ach vaccination, birds received 4.3 × 10−10 moles of recombinantanti-GST antibody.
protein for parity with previous studies [18,19]. The antigens were
mixed 1:1 with TiterMax Gold adjuvant (Sigma Aldrich, UK) and
delivered in two  subcutaneous injections of 50 l each on the
thorax using a 21 g 1′′ needle. Campylobacter enumeration was  per-
formed post-mortem at weekly intervals following challenge and
samples of blood collected for measurement of humoral responses.
At the end of each vaccination trial, enzyme-linked immunosor-
bent assays (ELISAs) were carried out to measure antigen-speciﬁc
serum IgY against FliD, FspA and CjaA, as described [18]. Coating
conditions were optimised using chequerboard analyses for each
antigen. Coating conditions were as follows: 0.5 g/ml GST-CjaA,
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Fig. 2. Campylobacter caecal colonisation levels and the induction of antigen-speciﬁc serum IgY following vaccination of chickens with recombinant GST-tagged Campylobacter
antigens. (A) Levels of C. jejuni M1  colonisation in the caeca of vaccinated chickens, sampled at weekly intervals at post-mortem examination. The lines show an inferred
course  of infection and not actual kinetics. Between 6 and 20 birds were sampled per week per treatment group. Data for FspA derive from two independent replicates
whereas  the other groups were tested in three independent trials. (B–D) Reactivity of sera collected from GST and GST-CjaA, GST-FspA and GST-FliD vaccinated birds to the
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iespective GST-tagged Campylobacter antigens expressed as average OD450nm. (E) R
verage OD450nm. For panels B–E error bars represent the standard error of the me
aecal Campylobacter counts on OD450nm readings obtained in ELISAs measuring rea
 g/ml GST-FliD and 1 g/ml GST-FspA. Serum was  diluted 1:500
n all ELISAs.
Statistical analyses were performed using Minitab 17 (Minitab,
K). A general linear model (GLM) and post hoc Dunnet’s tests were
sed to test for differences in caecal colonisation. A two-sided t-test
as used to assess changes in serum IgY compared to unvaccinated
ontrols only at each time-point. P values of ≤0.05 were considered
igniﬁcant.. Results
Typical preparations of antigens used for vaccination are shown
n Fig. 1A. Separate preparations of GST-FliD and GST-CjaA wereity of sera collected from each group of vaccinated birds to GST only expressed as
M) and asterisks denote statistical signiﬁcance at P < 0.05. (F) Linear regression of
 against GST-FliD in individual birds in the GST-FliD vaccinated group.
used for each vaccination trial and the same preparation of GST-
FspA and GST were used for all trials. In Western blots, the GST and
GST-FspA preparations gave a single species, whereas the GST-CjaA
and GST-FliD preparations contained a truncated variant corre-
sponding to the size of GST as well as the dominant fusion protein
(Fig. 1B), as observed previously [18]. This may  have inadvertently
resulted in administration of a lower molar quantity of the FliD and
CjaA antigens relative to other fusion proteins.
Following vaccination and homologous challenge with C. jejuni
in chickens, differences in caecal colonisation were analysed with
a second order hierarchical GLM taking into account interac-
tions between treatment group and time of sampling (R2 = 0.41).
When compared to GST-vaccinated controls, averaged across two
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iological replicates, GST-FspA failed to induce statistically signif-
cant reductions at any of the time intervals sampled (Fig. 2A). In
ontrast, in chickens vaccinated with GST-FliD a signiﬁcantly dif-
erent course of caecal Campylobacter colonisation was  observed
cross three independent studies, compared to both the GST
P < 0.001) and GST-CjaA (P < 0.001) vaccinated groups (Fig. 2A).
ost hoc Dunnet’s tests indicated that this was due to a signiﬁ-
ant and reproducible reduction present only at 49 days post-hatch
P < 0.001 when compared to both GST and GST-CjaA). A reduction
n caecal colonisation was absent one week later but the timing and
agnitude of the trend were consistently observed across each of
hree vaccination trials. As previously observed, GST-CjaA proved
ot to be protective [18], however, this is in contrast to our previ-
us studies using histidine-tagged CjaA in a different chicken line
19].
ELISA measurements of serum antigen-speciﬁc IgY in vaccinated
irds were used to assess immunogenicity of the vaccines and
hether antibody levels correlated with Campylobacter colonisa-
ion. A signiﬁcantly higher level of antigen-speciﬁc serum IgY was
etected in all vaccinated groups compared to the group vaccinated
ith GST only at all time intervals sampled (Fig. 2B–E), indicating
uccessful delivery and priming. However, in the GST-FliD vacci-
ated group, the kinetics of the serum IgY responses induced by
accination did not correspond to the time when reductions in
aecal Campylobacter numbers were observed. Furthermore, a pos-
tive correlation was observed between the magnitude of the
ntibody response and caecal Campylobacter counts in individual
irds in the GST-FliD vaccinated group (R2 = 0.18; P = 0.004; Fig. 2F).
his suggests that anti-FliD antibodies are unlikely to be associated
ith the protection observed. Furthermore these antibodies failed
o agglutinate C. jejuni in vitro or prevent bacterial motility in a soft
gar diffusion test (data not shown).
. Discussion
If widely applied, a vaccine that prevents or reduces Campy-
obacter colonisation of poultry could control human infection at
ts primary source. To circumvent the limitations of ﬂagellin-based
accines mentioned above, we tested the efﬁcacy of puriﬁed recom-
inant GST-FliD and GST-FspA, two ﬂagellum-related proteins, in
educing caecal Campylobacter colonisation. In contrast to studies
n mice using a 6xHis-tagged recombinant vaccine [16], no protec-
ion was observed using GST-FspA in chickens. This could be due to
ifferences in the afﬁnity tag used for puriﬁcation, dose of the vac-
ine or adjuvant used in this study or due to differences in the role
f FspA in Campylobacter infection in chickens and mice. Further
ork would be needed to determine the basis of this discrepancy.
Even though the FliD-based vaccine produced a c. 2 log10 CFU/g
eduction predicted by modelling to have an impact on human
nfections [2], the transient nature of protection, high cost of pro-
uction and need for repeated manual doses precludes commercial
sefulness. Protection may  differ if evaluated in a low dose chal-
enge model involving contaminated litter or seeder birds. The
hort-lived protection may  be due to immune evasion by C. jejuni
nvolving altered expression of FliD or the ﬂagellum. It is known
hat both expression [20] and glycosylation of ﬂagella is phase
ariable [10], however loss of motility may  be expected to be atten-
ating in the chicken unless other adaptations occur. Diminished
rotection could also be due to waning of the protective immune
esponse(s), and further work is needed to deﬁne the nature of
ell-mediated responses to vaccination and their association with
rotection. The lack of protection conferred by vaccination with
ST-CjaA was recently reported [18] and may  reﬂect use of a differ-
nt fusion protein, molar dose, adjuvant and bird line in the current
tudy compared to previous work [19]. The GST afﬁnity tag was
[e 34 (2016) 1739–1743
chosen as it has been claimed to produce higher yield and purity
proteins compared to the 6xHis tag and previous studies demon-
strated protection against Campylobacter using other GST-tagged
proteins [18]. However, its use may  have resulted in conforma-
tional changes in the case of CjaA which may  account for its lack
of protection relative to the His-tagged protein used elsewhere
[19]. Despite the difference in protection observed with FliD- and
FspA-based vaccines, both antigens induced signiﬁcant increases
in antigen-speciﬁc serum IgY levels compared to GST-only vacci-
nated control birds. This discrepancy and the positive correlation
observed between levels of anti-GST-FliD serum IgY and caecal
Campylobacter count in individual birds suggests that antibody may
not play a central role in protection, accepting that only IgY was
measured here and studies with Ig knockout birds are required to
formally exclude a role for antibody. Findings for the FliD-based
vaccine are consistent with our recent observations using a SodB-
based subunit vaccine which was  protective despite an apparent
lack of surface expression of SodB in C. jejuni [18]. Nevertheless
our study adds FliD to the limited repertoire of protective antigens
described to date, accepting that efﬁcacy is modest, transient and
unlikely to be suitable for commercial vaccines without signiﬁcant
further reﬁnement.
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